Literature DB >> 19643669

Novel insights into the biological function of mast cell carboxypeptidase A.

Gunnar Pejler1, Stefan D Knight, Frida Henningsson, Sara Wernersson.   

Abstract

When mast cells are activated they can respond by releasing their secretory granule compounds, including mast cell-specific proteases of chymase, tryptase and carboxypeptidase A (MC-CPA) type. MC-CPA is a dominant protein component of the mast cell granule and the MC-CPA gene is extremely highly expressed. Despite this, relatively little has been known of its biological function. However, the recent generation of mouse strains lacking MC-CPA has opened up new possibilities for investigations related to this protease. This recent development has revealed a role for MC-CPA in regulating innate immunity responses, including the degradation of harmful substances such as the vasoconstrictive factor endothelin 1 and snake venom toxins. Here, we summarize the current knowledge of MC-CPA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643669     DOI: 10.1016/j.it.2009.04.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  34 in total

1.  Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma.

Authors:  Ryan H Dougherty; Sukhvinder S Sidhu; Kavita Raman; Margaret Solon; Owen D Solberg; George H Caughey; Prescott G Woodruff; John V Fahy
Journal:  J Allergy Clin Immunol       Date:  2010-05       Impact factor: 10.793

2.  Involvement of mast cells in eosinophilic esophagitis.

Authors:  J Pablo Abonia; Carine Blanchard; Bridget Buckmeier Butz; Heather F Rainey; Margaret H Collins; Keith Stringer; Philip E Putnam; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-06-09       Impact factor: 10.793

Review 3.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

4.  Proteome-derived peptide libraries to study the substrate specificity profiles of carboxypeptidases.

Authors:  Sebastian Tanco; Julia Lorenzo; Javier Garcia-Pardo; Sven Degroeve; Lennart Martens; Francesc Xavier Aviles; Kris Gevaert; Petra Van Damme
Journal:  Mol Cell Proteomics       Date:  2013-04-25       Impact factor: 5.911

Review 5.  Mast cell chymase: morphofunctional characteristics.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2019-08-08       Impact factor: 4.304

6.  Substrate specificity of human carboxypeptidase A6.

Authors:  Peter J Lyons; Lloyd D Fricker
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

Review 7.  Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018).

Authors:  Sarfaraz Ahmad; Carlos M Ferrario
Journal:  Expert Opin Ther Pat       Date:  2018-10-10       Impact factor: 6.674

8.  Heparan sulfate 6-O-sulfotransferase isoform-dependent regulatory effects of heparin on the activities of various proteases in mast cells and the biosynthesis of 6-O-sulfated heparin.

Authors:  Md Ferdous Anower-E-Khuda; Hiroko Habuchi; Naoko Nagai; Osami Habuchi; Takashi Yokochi; Koji Kimata
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

9.  An immune response network associated with blood lipid levels.

Authors:  Michael Inouye; Kaisa Silander; Eija Hamalainen; Veikko Salomaa; Kennet Harald; Pekka Jousilahti; Satu Männistö; Johan G Eriksson; Janna Saarela; Samuli Ripatti; Markus Perola; Gert-Jan B van Ommen; Marja-Riitta Taskinen; Aarno Palotie; Emmanouil T Dermitzakis; Leena Peltonen
Journal:  PLoS Genet       Date:  2010-09-09       Impact factor: 5.917

10.  Maternal allergen exposure reprograms the developmental lung transcriptome in atopic and normoresponsive rat pups.

Authors:  Nicole Carpe; Isabel Mandeville; Alvin T Kho; Weiliang Qiu; James G Martin; Kelan G Tantisira; Benjamin A Raby; Scott T Weiss; Feige Kaplan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-09-14       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.